The winding path of Illumina/Grail
The European Commission’s decision to prohibit Illumina’s already-completed acquisition of Grail brought an end to the administrative stage of a legal saga that has attracted interest beyond competition law specialists. Norton Rose Fulbright partner Miranda Cole examines the case’s highly-debated implications for the EU merger control regime in light of both the commission’s ruling and the EU General Court’s remarks on the matter so far.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.